Investview Reports Steep Revenue Decline Amid Strategic Pivot
Event summary
- Q1 2026 revenue dropped 61.2% YoY to $3.9M, with net loss widening 574.4% to $2.8M.
- Conectiv DTC platform revenue fell 65.2% due to European network contraction post-UOKiK decision.
- $3.25M invested in next-gen nuclear power SPVs managed by Dream Ventures LLC.
- myLife Wellness launched as a dedicated commercial platform for health/wellness products.
- Opencash Securities brokerage platform delayed; full commercialization expected Q3 2026.
The big picture
Investview is pivoting from direct-to-consumer sales to a diversified platform combining health/wellness, financial services, and technology. The strategy aims to offset regulatory pressures in Europe and capitalize on emerging sectors like nuclear energy and digital brokerage. Success hinges on operational execution across multiple business units.
What we're watching
- Regulatory Headwinds
- Whether Investview can successfully appeal the UOKiK decision and restore European operations.
- Execution Risk
- The pace at which Opencash Securities achieves commercialization and scales revenue.
- Strategic Diversification
- How effectively the integration of myLife Wellness products into Conectiv's network drives growth.